Research Support Grant Programme

NUS Medicine OPA
Research Support Grant Programme


Applications ends 31st October 2025

A joint initiative by NUS Yong Loo Lin School of Medicine, Office of Postdoctoral Affairs and NovogeneAIT Genomics, in partnership with NTU Lee Kong Chian School of Medicine (LKC LEARN) and the Duke-NUS Medical School (DUNES), offering industry support and up to 50% off sequencing services.
Post-Doc Research Support Grant Banner

Are you a postdoctoral researcher ready to shape the future of science?

Now in its 2nd year, this programme supports early-career researchers with industry partnership and access to genomics services so promising projects can move toward meaningful outcomes. Proposals will be reviewed by a panel from NUS Medicine and NovogeneAIT Genomics, with awardees announced in early-mid November.

Eligibility

Open to postdoctoral researchers based in Singapore who obtained their PhD within the last 5 years.

Grant Tiers

  • 4 Awards of 50% discount
  • 10 Awards of 30% discount

Covers Novogene services across sequencing, proteomics, and metabolomics platforms.


Terms and Condition:
  • Maximum discount of S$3000 per grant winner.
  • Samples delivered to Novogene by 22nd December 2025.
  • Discounts extended from grant program cannot be combined with other existing promotions. Discounts are calculated off based on prevailing list pricing of eligible service offered by Novogene.

Why Apply?

  • Access to NovogeneAIT Genomics' local multiplatform sequencing capabilities.
  • Technical support from project inception to publication.
  • Visibility through outreach platforms and the scientific community.

Past Recipient Spotlight: Stephen Kwa


Stephen Kwa, from the Gastrointestinal Microbiome & Molecular Laboratory at NUS Medicine (Assistant Prof. Jonathan Lee’s lab), shares how the grant accelerated his research—and how it could support yours.

Read on for the complete interview, where he expands on his experiences in greater detail.
FAQ Accordion
Q. What’s your research focus? +

My research centers on characterizing gut microbes and their role in producing metabolites that are known to impact host metabolism and inflammation. We are currently isolating microbes and sequencing their genomes to investigate the genetic basis of these metabolic pathways and their potential relevance to gastrointestinal and metabolic diseases.

Q. How does Shotgun Metagenomics sequencing help in your investigation in identifying the gut microbiome? +

Shotgun metagenomic sequencing provides comprehensive and unbiased insights into the microbial community structure and functional capacity. Unlike targeted approaches, it allows us to identify microbes at the species or strain level and simultaneously characterize their gene content. With deep sequencing on NovaSeq, we can even pick up low-abundance microbes that play critical roles, which we might miss otherwise.

Q. How has this postdoc grant supported your research in terms of resources and advancing your experimental design? +

This grant really helped bring our ideas to life. It gave us access to advanced sequencing platforms, including both short- and long-read technologies, which are essential for building high-quality microbial genomes. The funding allowed us to transition from purely observational studies to more mechanistic investigations, adding greater value to our findings and potential clinical relevance.

Q. Did receiving this grant have any indirect benefits such as boosting your CV, or opening up other opportunities? +

Yes, definitely. Receiving this grant not only supported my research but also added strong credibility to my CV. It also enhanced my visibility in the research community, leading to new collaborations, speaking invitations, and further funding opportunities. The recognition associated with the award helped position me as a credible contributor in the field of microbiome and metabolic research.

Q. What advice would you give to other early-career researchers seeking similar small grants? +

Keep it simple and focused. You don’t need a huge project — just one that’s achievable and clearly explained. Show how this small grant will directly move your work forward, whether it's generating pilot data or testing a new method. And get feedback from colleagues before submitting, that helps a lot. Also, even if it doesn’t work out the first time, keep trying. Each application improves your skills and increases your chances next round.

Q. How do you see advancements in sequencing technology transforming microbiome research over the next 5 years? +

Sequencing is evolving fast. Over the next five years, I expect these tools to become more accessible and widely integrated into microbiome research workflows. Combined with improved annotation pipelines and integrative omics approaches, they will facilitate a deeper understanding of microbial functions and interactions with the host. This progress will accelerate the translation of microbiome research into clinical diagnostics and personalized therapeutics.

Our Innovative Platforms and Technologies

Launch Event @NUS MD6 | 5 Sept, 12.30pm–2pm

Join us on 5 September for an afternoon of community vibes. Get tips to strengthen your grant application, then stay for old-school ice cream, crispy chicken bites, popcorns and swags.

Why join?

  • Connect with fellow postdocs (NUS OPA, LEARNLKC, DUNES) and leading partners BD, Twist Bioscience, Olink, and PacBio — communities dedicated to supporting postdoc-led discoveries.
  • Gain fresh perspectives from experts in spotlight talks offering practical insights into the tools and workflows that matter for your research.
Proudly presented and supported by

Submissions open till 31st October 2025. Submit your proposal below.

Grant Proposal Submission



Upon grant award, a PDF of the supervisor’s email approval will be required from the awardees

By registering on this page, you are consenting and agreeing for NUS Yong Loo Lin School of Medicine, Office of Postdoctoral Affairs and NovogeneAIT Genomics to contact you, assist with your request, and store your information per our privacy policy. You can change your email preferences at any time.
 
 
 
About Novogene
Novogene is a pioneer in applying cutting-edge molecular biology technology and high-performance computing to research in the fields of life science and human health. Our vision is to continue as a global leader in the delivery of genomics services and solutions. With one of the largest sequencing capacities in the world, we utilise our deep scientific knowledge, first-class customer service and unsurpassed data quality to help clients realise their research goals in the rapidly evolving world of genomics. Novogene is committed to become your trusted genomics partner.
 
For more information, visit novogene.com/amea-en
in   N   X   X   f
© 2025 Novogene Co., Ltd. All Rights Reserved.
For Research Use Only. Not for Clinical Diagnostic Use.
Regional Office for Asia Pacific, Middle-East & Africa:
NovogeneAIT Genomics Pte. Ltd.
11 Biopolis Way, #10-11 Helios,
Singapore 138667  
 
Novogene (HK) Company Limited
Unit 1307, Everglory Centre,
1B Kimberly Street, 
Tsim Sha Tsui, Hong Kong
Novogene Japan K.K.
Kayabacho-Nagaoka BLDG3-7F, 2-7-10,
Nihonbashi-Kayabacho, Chuo City,
Tokyo,103-0025 Japan
 
Novogene Korea
Mediopen Lab 503, 5th Floor,
Korea Health Management Association,
372 Hwagok-ro, Gangseo-gu,
Seoul, Republic of Korea